The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Advanced Drug Delivery-Global Market Insights and Sales Trends 2024
Synopsis
Advanced Drug Delivery refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
The global Advanced Drug Delivery market size is expected to reach US$ 17250 million by 2029, growing at a CAGR of 18.6% from 2023 to 2029. The market is mainly driven by the significant applications of Advanced Drug Delivery in various end use industries. The expanding demands from the Hospitals, Diagnostic Centers, Ambulatory Surgical Centers/Clinics and Home Care Settings, are propelling Advanced Drug Delivery market. Polymeric Drug Delivery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implants & IUD's segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Advanced Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Advanced Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Advanced Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Advanced Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Advanced Drug Delivery covered in this report include Merck & Co, Antares Pharma, F. Hoffmann-La Roche, Novartis, Bayer, Sanofi, Glaxosmithkline, 3M and Pfizer, etc.
The global Advanced Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Global Advanced Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Advanced Drug Delivery market, Segment by Type:
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Global Advanced Drug Delivery market, by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Advanced Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Advanced Drug Delivery refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
The global Advanced Drug Delivery market size is expected to reach US$ 17250 million by 2029, growing at a CAGR of 18.6% from 2023 to 2029. The market is mainly driven by the significant applications of Advanced Drug Delivery in various end use industries. The expanding demands from the Hospitals, Diagnostic Centers, Ambulatory Surgical Centers/Clinics and Home Care Settings, are propelling Advanced Drug Delivery market. Polymeric Drug Delivery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implants & IUD's segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Advanced Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Advanced Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Advanced Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Advanced Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Advanced Drug Delivery covered in this report include Merck & Co, Antares Pharma, F. Hoffmann-La Roche, Novartis, Bayer, Sanofi, Glaxosmithkline, 3M and Pfizer, etc.
The global Advanced Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Global Advanced Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Advanced Drug Delivery market, Segment by Type:
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Global Advanced Drug Delivery market, by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Advanced Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Advanced Drug Delivery
1.1 Advanced Drug Delivery Market Overview
1.1.1 Advanced Drug Delivery Product Scope
1.1.2 Advanced Drug Delivery Market Status and Outlook
1.2 Global Advanced Drug Delivery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Advanced Drug Delivery Market Size by Region (2018-2029)
1.4 Global Advanced Drug Delivery Historic Market Size by Region (2018-2023)
1.5 Global Advanced Drug Delivery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Advanced Drug Delivery Market Size (2018-2029)
1.6.1 North America Advanced Drug Delivery Market Size (2018-2029)
1.6.2 Europe Advanced Drug Delivery Market Size (2018-2029)
1.6.3 Asia-Pacific Advanced Drug Delivery Market Size (2018-2029)
1.6.4 Latin America Advanced Drug Delivery Market Size (2018-2029)
1.6.5 Middle East & Africa Advanced Drug Delivery Market Size (2018-2029)
2 Advanced Drug Delivery Market by Type
2.1 Introduction
2.1.1 Polymeric Drug Delivery
2.1.2 Implants & IUD's
2.1.3 Sustained Release
2.1.4 Targeted Drug Delivery
2.1.5 Prodrugs
2.2 Global Advanced Drug Delivery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Advanced Drug Delivery Historic Market Size by Type (2018-2023)
2.2.2 Global Advanced Drug Delivery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Advanced Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Advanced Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Advanced Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Advanced Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Advanced Drug Delivery Revenue Breakdown by Type (2018-2029)
3 Advanced Drug Delivery Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Centers
3.1.3 Ambulatory Surgical Centers/Clinics
3.1.4 Home Care Settings
3.1.5 Other End Users
3.2 Global Advanced Drug Delivery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Advanced Drug Delivery Historic Market Size by Application (2018-2023)
3.2.2 Global Advanced Drug Delivery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Advanced Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Advanced Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Advanced Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Advanced Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Advanced Drug Delivery Revenue Breakdown by Application (2018-2029)
4 Advanced Drug Delivery Competition Analysis by Players
4.1 Global Advanced Drug Delivery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Advanced Drug Delivery as of 2022)
4.3 Date of Key Players Enter into Advanced Drug Delivery Market
4.4 Global Top Players Advanced Drug Delivery Headquarters and Area Served
4.5 Key Players Advanced Drug Delivery Product Solution and Service
4.6 Competitive Status
4.6.1 Advanced Drug Delivery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck & Co
5.1.1 Merck & Co Profile
5.1.2 Merck & Co Main Business
5.1.3 Merck & Co Advanced Drug Delivery Products, Services and Solutions
5.1.4 Merck & Co Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.1.5 Merck & Co Recent Developments
5.2 Antares Pharma
5.2.1 Antares Pharma Profile
5.2.2 Antares Pharma Main Business
5.2.3 Antares Pharma Advanced Drug Delivery Products, Services and Solutions
5.2.4 Antares Pharma Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.2.5 Antares Pharma Recent Developments
5.3 F. Hoffmann-La Roche
5.3.1 F. Hoffmann-La Roche Profile
5.3.2 F. Hoffmann-La Roche Main Business
5.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Advanced Drug Delivery Products, Services and Solutions
5.4.4 Novartis Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Bayer
5.5.1 Bayer Profile
5.5.2 Bayer Main Business
5.5.3 Bayer Advanced Drug Delivery Products, Services and Solutions
5.5.4 Bayer Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Recent Developments
5.6 Sanofi
5.6.1 Sanofi Profile
5.6.2 Sanofi Main Business
5.6.3 Sanofi Advanced Drug Delivery Products, Services and Solutions
5.6.4 Sanofi Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.6.5 Sanofi Recent Developments
5.7 Glaxosmithkline
5.7.1 Glaxosmithkline Profile
5.7.2 Glaxosmithkline Main Business
5.7.3 Glaxosmithkline Advanced Drug Delivery Products, Services and Solutions
5.7.4 Glaxosmithkline Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.7.5 Glaxosmithkline Recent Developments
5.8 3M
5.8.1 3M Profile
5.8.2 3M Main Business
5.8.3 3M Advanced Drug Delivery Products, Services and Solutions
5.8.4 3M Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.8.5 3M Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Advanced Drug Delivery Products, Services and Solutions
5.9.4 Pfizer Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 Johnson & Johnson
5.10.1 Johnson & Johnson Profile
5.10.2 Johnson & Johnson Main Business
5.10.3 Johnson & Johnson Advanced Drug Delivery Products, Services and Solutions
5.10.4 Johnson & Johnson Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.10.5 Johnson & Johnson Recent Developments
5.11 Abbott Laboratories
5.11.1 Abbott Laboratories Profile
5.11.2 Abbott Laboratories Main Business
5.11.3 Abbott Laboratories Advanced Drug Delivery Products, Services and Solutions
5.11.4 Abbott Laboratories Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.11.5 Abbott Laboratories Recent Developments
5.12 Allergan
5.12.1 Allergan Profile
5.12.2 Allergan Main Business
5.12.3 Allergan Advanced Drug Delivery Products, Services and Solutions
5.12.4 Allergan Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.12.5 Allergan Recent Developments
5.13 Baxter International
5.13.1 Baxter International Profile
5.13.2 Baxter International Main Business
5.13.3 Baxter International Advanced Drug Delivery Products, Services and Solutions
5.13.4 Baxter International Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.13.5 Baxter International Recent Developments
5.14 Mylan Pharmaceutical
5.14.1 Mylan Pharmaceutical Profile
5.14.2 Mylan Pharmaceutical Main Business
5.14.3 Mylan Pharmaceutical Advanced Drug Delivery Products, Services and Solutions
5.14.4 Mylan Pharmaceutical Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.14.5 Mylan Pharmaceutical Recent Developments
5.15 Roche Holding
5.15.1 Roche Holding Profile
5.15.2 Roche Holding Main Business
5.15.3 Roche Holding Advanced Drug Delivery Products, Services and Solutions
5.15.4 Roche Holding Advanced Drug Delivery Revenue (US$ Million) & (2018-2023)
5.15.5 Roche Holding Recent Developments
6 North America
6.1 North America Advanced Drug Delivery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Advanced Drug Delivery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Advanced Drug Delivery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Advanced Drug Delivery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Advanced Drug Delivery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Advanced Drug Delivery Market Dynamics
11.1 Advanced Drug Delivery Industry Trends
11.2 Advanced Drug Delivery Market Drivers
11.3 Advanced Drug Delivery Market Challenges
11.4 Advanced Drug Delivery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
